Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive dexamethasone or diclofenac before endodontic treatment for symptomatic irreversible pulpitis
RBR-4y22q9zCompleted
- Sponsor
- São Leopoldo Mandic
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone, diclofenac and Placebo-COD Research Private Ltd in pulpitis (3 arms), sponsored by São Leopoldo Mandic. Started Sep 2021; status: completed.
02
Drugs
dexamethasonediclofenacPlacebo-COD Research Private Ltd
03
Conditions
pulpitis
Beyond the preview
Go deeper on RBR-4y22q9z.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4y22q9z.